BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Jul 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-07-06

Reporting Person: Olson Scott (SVP & Pres, Rhythm Management)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10578.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Deferred Stock Units	$	2023-02-15	Common Stock (3876.0000)		Direct
Deferred Stock Units	$	2024-02-18	Common Stock (4150.0000)		Direct
Deferred Stock Units	$	2023-02-21	Common Stock (3271.0000)		Direct
Deferred Stock Units	$	2022-02-28	Common Stock (2852.0000)		Direct
Deferred Stock Units	$	2024-07-01	Common Stock (7086.0000)		Direct
Deferred Stock Units	$	2020-12-01	Common Stock (1485.0000)		Direct
Stock Option (Right to Buy)	$13.0800	2024-02-24	Common Stock (5625.0000)		Direct
Stock Option (Right to Buy)	$18.5200	2025-12-01	Common Stock (14851.0000)		Direct
Stock Option (Right to Buy)	$24.5500	2027-02-28	Common Stock (18939.0000)		Direct
Stock Option (Right to Buy)	$27.0900	2028-02-15	Common Stock (15756.0000)		Direct
Stock Option (Right to Buy)	$35.2800	2030-07-01	Common Stock (29239.0000)		Direct
Stock Option (Right to Buy)	$40.1200	2029-02-21	Common Stock (15060.0000)		Direct
Stock Option (Right to Buy)	$42.1600	2030-02-18	Common Stock (16843.0000)		Direct

Footnotes

F1: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

F2: This amount represents the unvested portion of DSUs awarded on February 15, 2018, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F6: This amount represents the unvested portion of DSUs awarded on February 21, 2019, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F7: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

F8: This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in two remaining installments on the anniversary of the date of grant.

F9: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant.

F10: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.

F11: This amount represents the unvested portion of DSUs awarded on December 1, 2015, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F12: Grant to the reporting person of an option to purchase 22,500 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F13: Grant to the reporting person of an option to purchase 22,467 shares of common stock vesting in four equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.

F14: Grant to the reporting person of an option to purchase 25,252 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

F15: Grant to the reporting person of an option to purchase 21,008 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.

F16: Grant to the reporting person of an option to purchase 29,239 shares of common stock vesting in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant.

F17: Grant to the reporting person of an option to purchase 15,060 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F18: Grant to the reporting person of an option to purchase 16,843 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.